GLP1RAs significantly decreased E-wave velocity, E/A ratio, E/e _ ratio, and EDT but did not affect LVEF
Nilsson O, Bilchik AJ, Goldenring JR, Ballantyne GH, Adrian TE, and Modlin IM
Overall, 36 percent of employers are providing GLP-1 coverage for both diabetes and weight loss (up from 34 percent in 2024)
They argued that selectivity would improve safety while still providing acceptable efficacy
After reviewing your health and insurance information, Ro determines your coverage options and delivers a free, easy-to-understand report with care options, treatment plans, and estimated co-pays
As obesity becomes more firmly recognized as a chronic metabolic disease, the gap between diabetes and weight loss treatment pathways may narrow